Loss of Jab1 in Osteochondral Progenitor Cells Severely Impairs Embryonic Limb Development in Mice

Journal of Cellular Physiology

Volumn 229, Issue 11, 2014, Pages 1607-1617

  Bashur, Lindsay A ^a   Chen, Dongxing ^a   Chen, Zhijun ^a   Liang, Bojian ^a,d   Pardi, Ruggero ^b   Murakami, Shunichi ^a   Zhou, Guang ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ALCIAN BLUE; COLLAGEN TYPE 0A1; COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; INHIBITOR OF DIFFERENTIATION 1; JAB1 PROTEIN; NOGGIN; PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

AGGRECAN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIRTH; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; COL10A1 GENE; COL2A1 GENE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; EX VIVO STUDY; GENE; GENE DELETION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; ID1 GENE; IHH GENE; JAB1 GENE; KNOCKOUT MOUSE; LIMB BUD; LIMB DEFORMITY; LIMB DEVELOPMENT; MESENCHYME CELL; MOUSE; MUTANT MOUSE STRAIN; NOGGIN GENE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOX9 GENE; TRANSGENE;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; EMBRYONIC DEVELOPMENT; EXTREMITIES; GENE DELETION; HOMEODOMAIN PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PEPTIDE HYDROLASES; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; STEM CELLS;

EID: 84904862821     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24602     Document Type: Article

References (47)

1. Akiyama H. 2008. Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18:213-219.
2. Akiyama H, Lefebvre V. 2011. Unraveling the transcriptional regulatory machinery in chondrogenesis. J Bone Miner Metab 29:390-395.
3. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828.
4. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T, de Crombrugghe B. 2005. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102:14665-14670.
5. Bruce SJ, Butterfield NC, Metzis V, Town L, McGlinn E, Wicking C. 2010. Inactivation of Patched1 in the mouse limb has novel inhibitory effects on the chondrogenic program. J Biol Chem 285:27967-27981.
6. Chamovitz DA. 2009. Revisiting the COP9 signalosome as a transcriptional regulator. EMBO Rep 10:352-358.
7. Chamovitz DA, Segal D. 2001. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep 2:96-101.
8. Chen D, Zhao M, Mundy GR. 2004. Bone morphogenetic proteins. Growth Factors 22:233-241.
9. Chen G, Deng C, Li YP. 2012. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8:272-288.
10. Chen D, Bashur LA, Liang B, Panattoni M, Tamai K, Pardi R, Zhou G. 2013. The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo. J Cell Sci 126:234-243.
11. Claret FX, Hibi M, Dhut S, Toda T, Karin M. 1996. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383:453-457.
12. Dolk H, Loane M, Garne E. 2010. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 686:349-364.
13. Dong Y, Jesse AM, Kohn A, Gunnell LM, Honjo T, Zuscik MJ, O'Keefe RJ, Hilton MJ. 2010. RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development 137:1461-1471.
14. Dranse HJ, Sampaio AV, Petkovich M, Underhill TM. 2011. Genetic deletion of Cyp26b1 negatively impacts limb skeletogenesis by inhibiting chondrogenesis. J Cell Sci 124:2723-2734.
15. Galloway JL, Delgado I, Ros MA, Tabin CJ. 2009. A reevaluation of X-irradiation-induced phocomelia and proximodistal limb patterning. Nature 460:400-404.
16. Huang J, Yuan H, Lu C, Liu X, Cao X, Wan M. 2007. Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. J Mol Biol 371:514-527.
17. Kato JY, Yoneda-Kato N. 2009. Mammalian COP9 signalosome. Genes Cells 14:1209-1225.
18. Kawanami A, Matsushita T, Chan YY, Murakami S. 2009. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun 386:477-482.
19. Kim BC, Lee HJ, Park SH, Lee SR, Karpova TS, McNally JG, Felici A, Lee DK, Kim SJ. 2004. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol 24:2251-2262.
20. Kobayashi T, Lyons KM, McMahon AP, Kronenberg HM. 2005. BMP signaling stimulates cellular differentiation at multiple steps during cartilage development. Proc Natl Acad Sci USA 102:18023-18027.
21. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-336.
22. Kyono A, Avishai N, Ouyang Z, Landreth GE, Murakami S. 2012. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation. J Bone Miner Metab 30:19-30.
23. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346.
24. Lefebvre V, Li P, de Crombrugghe B. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733.
25. Liang B, Cotter MM, Chen D, Hernandez CJ, Zhou G. 2012. Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties. Calcif Tissue Int 90:76-89.
26. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, Tabin CJ. 2002. Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis 33:77-80.
27. Long F, Ornitz DM. 2013. Development of the endochondral skeleton. Cold Spring Harb Perspect Biol 5:a008334.
28. Mak KK, Chen MH, Day TF, Chuang PT, Yang Y. 2006. Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133:3695-3707.
29. Pan Q, Yu Y, Chen Q, Li C, Wu H, Wan Y, Ma J, Sun F. 2008. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol 217:228-241.
30. Panattoni M, Sanvito F, Basso V, Doglioni C, Casorati G, Montini E, Bender JR, Mondino A, Pardi R. 2008. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J Exp Med 205:465-477.
31. Richardson KS, Zundel W. 2005. The emerging role of the COP9 signalosome in cancer. Mol Cancer Res 3:645-653.
32. Shackleford TJ, Claret FX. 2010. JAB1/CSN5: A new player in cell cycle control and cancer. Cell Div 5:26.
33. Shola DT, Wang H, Wahdan-Alaswad R, Danielpour D. 2012. Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8. Oncogene 31:2480-2490.
34. Shu B, Zhang M, Xie R, Wang M, Jin H, Hou W, Tang D, Harris SE, Mishina Y, O'Keefe RJ, Hilton MJ, Wang Y, Chen D. 2011. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci 124:3428-3440.
35. Song B, Estrada KD, Lyons KM. 2009. Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev 20:379-388.
36. Tian L, Peng G, Parant JM, Leventaki V, Drakos E, Zhang Q, Parker-Thornburg J, Shackleford TJ, Dai H, Lin SY, Lozano G, Rassidakis GZ, Claret FX. 2010. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene 29:6125-6137.
37. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. 2004. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 279:43013-43018.
38. Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Wang N. 2002. Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep 3:171-176.
39. Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, Lemerrer M, Mortier G, Mundlos S, Nishimura G, Rimoin DL, Robertson S, Savarirayan R, Sillence D, Spranger J, Unger S, Zabel B, Superti-Furga A. 2010. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 155:943-968.
40. Wei N, Deng XW. 2003. The COP9 signalosome. Annu Rev Cell Dev Biol 19:261-286.
41. Wei N, Serino G, Deng XW. 2008. The COP9 signalosome: More than a protease. Trends Biochem Sci 33:592-600.
42. Yang KT, Wang MC, Chen JY, Hsu MC, Hung WC. 2011. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of beta-catenin and STAT1 in chronic myeloid leukemia cells. J Cell Physiol 226:2849-2856.
43. Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM. 2005. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci USA 102:5062-5067.
44. Yoshida A, Yoneda-Kato N, Panattoni M, Pardi R, Kato JY. 2010. CSN5/Jab1 controls multiple events in the mammalian cell cycle. FEBS Lett 584:4545-4552.
45. Zhou G, Lefebvre V, Zhang Z, Eberspaecher H, de Crombrugghe B. 1998. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273:14989-14997.
46. Zhou G, Chen Y, Zhou L, Thirunavukkarasu K, Hecht J, Chitayat D, Gelb BD, Pirinen S, Berry SA, Greenberg CR, Karsenty G, Lee B. 1999. CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum Mol Genet 8:2311-2316.
47. Zhou G, Zheng Q, Engin F, Munivez E, Chen Y, Sebald E, Krakow D, Lee B. 2006. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103:19004-19009.